bluebird bio Inc (LTS:0HOH)
$ 0.3637 0 (0%) Market Cap: 73.46 Mil Enterprise Value: 371.21 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

bluebird bio Inc at Wells Fargo Virtual Healthcare Conference Transcript

Sep 10, 2020 / 08:00PM GMT
Release Date Price: $57.04
Yanan Zhu
Wells Fargo Securities, LLC, Research Division - Associate Analyst

Welcome, everyone. My name is Yanan Zhu, and I'm a senior biotech analyst here at Wells Fargo. It's my great pleasure to introduce bluebird, bluebird bio. And with us today are Chip Baird, Chief Financial Officer; and Dave Davidson, Chief Medical Officer. So thanks, Chip and Dave, for participating in our fireside chat session.

Questions & Answers

Yanan Zhu
Wells Fargo Securities, LLC, Research Division - Associate Analyst

To start off, I'm just wondering if we could ask -- if I could ask about the recent cost reduction measures that you put in place in the last few months and the potential impact on extending cash runway?

William D. Baird
bluebird bio, Inc. - CFO

Sure. Happy to take that one, and I appreciate being invited to be part of this year's Wells Fargo conference. Great to be here.

In terms of the cash runway, I think that's part of a broader story around bluebird and just kind of where we see ourselves today

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot